Trials / Completed
CompletedNCT00619775
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 419 (actual)
- Sponsor
- Medtronic Endovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and efficacy of the Protege Stent and Spider Device in the treatment of common and/or internal carotid artery stenoses for subjects that are high risk for carotid endarterectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PROTÉGÉ® GPS™ and PROTÉGÉ® RX Carotid Stent Systems and Spider Embolic Protection Device | Carotid artery stenting with distal embolic protection. |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-10-01
- First posted
- 2008-02-21
- Last updated
- 2021-05-14
Locations
31 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00619775. Inclusion in this directory is not an endorsement.